Prospective validation of the Baylor bleeding score for predicting the likelihood of rebleeding after endoscopic hemostasis of peptic ulcers

Gastrointest Endosc. 1995 Jun;41(6):561-5. doi: 10.1016/s0016-5107(95)70191-5.


Endoscopic therapy is effective in securing hemostasis for bleeding ulcers, but bleeding recurs in 10% to 30% of patients. Prospective identification of patients at increased risk for rebleeding is requisite to reducing rebleeding rates. We previously developed a three-component scoring system that identifies patients at increased risk for rebleeding. In the present study, we prospectively validated our scoring system. Forty-seven men ranging in age from 23 to 95 years in whom endoscopic therapy for bleeding ulcers was successful were studied. Patients with pre-endoscopy scores greater than 5 or postendoscopy scores greater than 10 were stratified as high-risk, and patients with pre-endoscopy scores of 5 or less and post-endoscopy scores of 10 or less as low-risk. Twenty-six patients were categorized as high-risk and 19 as low-risk. All patients were followed until discharged from the hospital. The rebleeding rate for high-risk patients was 31% (8 of 26), compared with 0 for low-risk patients (p < .05). We conclude that our scoring system accurately predicts patients at increased risk for rebleeding after successful endoscopic therapy of bleeding ulcers.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Chi-Square Distribution
  • Duodenal Ulcer / complications*
  • Follow-Up Studies
  • Hemostasis, Endoscopic / methods
  • Hemostasis, Endoscopic / statistics & numerical data*
  • Humans
  • Male
  • Middle Aged
  • Peptic Ulcer Hemorrhage / therapy*
  • Prognosis
  • Prospective Studies
  • Recurrence
  • Reproducibility of Results
  • Risk Factors
  • Statistics, Nonparametric
  • Stomach Ulcer / complications*